From: Comparative efficacy of oral administrated afoxolaner (NexGard™) and fluralaner (Bravecto™) with topically applied permethrin/imidacloprid (Advantix®) against transmission of Ehrlichia canis by infected Rhipicephalus sanguineus ticks to dogs
Number infected (proportion)
Efficacy (%)
Control
Advantix®
NexGard™
Bravecto™
Control versus Advantix®
Control versus NexGard™
Control versus Bravecto™
6/29 (0.2068966)
0/32 (0)
4/32 (0.125)
2/32 (0.0625)
100.0
39.6
69.8